Grants and Contributions:
Title:
Project Bedrock
Agreement Number:
819532
Agreement Value:
$49,900,000.00
Agreement Date:
Mar 7, 2025 - Jul 1, 2050
Description:
These two biomanufacturing Good Manufacturing Practices (GMP) facilities will be established to enable the production of essential Messenger Ribonucleic Acid (mRNA) vaccines, viral diagnostics and antibody therapeutic inputs at a large scale of up to 5000 litres per batch.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
This investment will help strengthen Canada's biomanufacturing industrial base, bolster participation in global supply chains and reinforce pandemic readiness by allowing the company to scale up their current operations to support commercial production.
Location:
Vancouver, British Columbia, CA V6A1B6
Reference Number:
033-2024-2025-Q4-819532
Agreement Type:
Other transfer payment
Report Type:
Grants and Contributions
Recipient Business Number:
135714426
Recipient Type:
For-profit organization
Additional Information:
This is a partially unconditionally repayable contribution.
Recipient's Operating Name:
STEMCELL Technologies Canada Inc.
Recipient's Legal Name:
STEMCELL Technologies Canada Inc.
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
SIF Stream2- Growth
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
339990